4,4-difluoro-1,2,3,4-tetrahydro-5H-1-be nzazepine derivative or salt thereof

Details for Australian Patent Application No. 2004234258 (hide)

Owner Astellas Pharma Inc.

Inventors Koshio, Hiroyuki; Akamatsu, Seijiro; Tsukamoto, Issei; Kakefuda, Akio; Saitoh, Chikashi

Agent Davies Collison Cave

Pub. Number AU-B-2004234258

PCT Pub. Number WO2004/096775

Priority 2003-123032 28.04.03 JP; 2003-401126 01.12.03 JP

Filing date 26 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 9 April 2009

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096775 Priority application(s): WO2004/096775

9 April 2009 Application Accepted

  Published as AU-B-2004234258

6 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234282-Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein

2004234256-Heat-shrinkable layered film and package made with the same